KA
CO

Kerrisdale Advisers’s Global Cord Blood Corporation CO Stock Holding History

Kerrisdale Advisers’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-66,012
Closed -$185K – 80
2013
Q2 		$185K Buy
+66,012
New +$188K 0.09% 56

Other funds holding CO

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kerrisdale Advisers's CO Position: Q3 2013 in Review

Kerrisdale Advisers sold out of Global Cord Blood Corporation (CO) in Q3 2013, closing a stake of 66,012 shares — an estimated $185K sold.

Kerrisdale Advisers first reported a position in CO in Q2 2013 and held it in 1 quarter. The position peaked at $185K in Q2 2013. 22 funds tracked by Wall St. Rank hold CO as of Q3 2013.

  • Kerrisdale Advisers reported no remaining Global Cord Blood Corporation position as of Q3 2013 after selling out during the quarter.
  • Kerrisdale Advisers sold 66,012 Global Cord Blood Corporation shares in Q3 2013, an estimated $185K.
  • Kerrisdale Advisers first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 1 quarter.
  • Kerrisdale Advisers's Global Cord Blood Corporation position peaked at $185K in Q2 2013.
  • 22 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2013.

Based on Kerrisdale Advisers's 13F filing for Q3 2013, filed 14 Nov 2013.